Also Noted

Use of home monitoring devices to hit 19.1M, report says

 - 
06/27/2014

YARMOUTH, Maine – Three million patients used connected home medical monitoring devices worldwide at the end of 2013, according to a new report from Berg Insights.

Separate benefit bill lands more co-sponsors

 - 
06/26/2014

WASHINGTON – Twenty-three more lawmakers have signed on to co-sponsor bills to create a separate benefit for complex rehab in the last month, according to an email bulletin from NCART Executive Director Don Clayback.

Review finds 63% error rate for CPAP devices

 - 
06/26/2014

FARGO, N.D. – A pre-payment review by Noridian found potential improper payment rates of 63% for CPAP devices from February to May 2014.

Hasco’s Ride-Away to market BraunAbility vans in Baltimore

 - 
06/26/2014

ADDISON, Texas and BALTIMORE – Hasco Medical subsidiary Ride-Away, a provider of handicap-accessible vans, parts and services, has secured the rights to market BraunAbility wheelchair accessible vans in the Baltimore area.

Lawmakers extend deadline for letter

 - 
06/25/2014

WASHINGTON – The deadline has been extended for the “Dear Colleague” letter asking the Office of Inspector General (OIG) to study the impact

Study: Pharmacists can help reduce hospital readmissions

 - 
06/25/2014

YARMOUTH, Maine – Hospital readmissions could be reduced by 20% if high-risk patients received counseling and medication management from a community pharmacist, according to a new study from the University of Cincinnati’s James L. Winkle College of Pharmacy.

CareTouch offers billing system integration

 - 
06/25/2014

WESTMINSTER, Colo. – CareTouch Communications has enhanced its CareTouch360 platform to communicate with most billing systems.

Inogen makes play in stationary market

 - 
06/24/2014

GOLETA, Calif. – Inogen has received clearance from the U.S. Food and Drug Administration (FDA) for a home oxygen concentrator called Inogen At Home.

MEDIchair goes private equity

 - 
06/24/2014

TORONTO – Centric Health has entered into a definitive agreement to sell its MEDIchair and Motion Specialties retail home medical operations to Canadian-based Birch Hill Equity Partners for $50 million.

ResMed CEO sells 3,200 shares

 - 
06/19/2014

NEW YORK – ResMed CEO Michael Farrell sold 3,200 shares of company stock on the open market June 16.

Pages